| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-19 | GILEAD SCIENCES, INC. | LEAP THERAPEUTICS, INC. | 5,319,148 | 13.9% | EDGAR |
| SC 13G | 2024-04-05 | GILEAD SCIENCES, INC. | Xilio Therapeutics, Inc. | 7,345,473 | 19.9% | EDGAR |
| SC 13G | 2024-02-20 | GILEAD SCIENCES, INC. | Kyverna Therapeutics, Inc. | 4,126,119 | 9.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | GILEAD SCIENCES, INC. | 111,820,711 | 9.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GILEAD SCIENCES, INC. | Tango Therapeutics, Inc. | 4,854,443 | 4.8% | EDGAR |
| SC 13G/A | 2024-02-13 | GILEAD SCIENCES, INC. | Allovir, Inc. | 16,635,286 | 14.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital World Investors | GILEAD SCIENCES, INC. | 83,698,215 | 6.7% | EDGAR |
| SC 13D/A | 2024-01-31 | GILEAD SCIENCES, INC. | Arcus Biosciences, Inc. | 31,532,781 | 35.0% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | GILEAD SCIENCES, INC. | 122,790,297 | 9.9% | EDGAR |
| SC 13G/A | 2023-12-28 | GILEAD SCIENCES, INC. | Arcellx, Inc. | 6,720,803 | 12.9% | EDGAR |
| SC 13G/A | 2023-12-22 | GILEAD SCIENCES, INC. | HOOKIPA Pharma Inc. | 18,759,465 | 19.4% | EDGAR |
| SC 13D | 2023-10-25 | GILEAD SCIENCES, INC. | ASSEMBLY BIOSCIENCES, INC. | 13,073,668 | 19.9% | EDGAR |
| SC 13G | 2023-10-19 | GILEAD SCIENCES, INC. | Ikena Oncology, Inc. | 2,931,467 | 6.7% | EDGAR |
| SC 13D/A | 2023-07-06 | GILEAD SCIENCES, INC. | Arcus Biosciences, Inc. | 25,586,953 | 35.0% | EDGAR |
| SC 13G/A | 2023-02-14 | GILEAD SCIENCES, INC. | HOOKIPA Pharma Inc. | 3,759,465 | 7.2% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital Research Global Investors | GILEAD SCIENCES, INC. | 54,602,952 | 4.4% | EDGAR |
| SC 13G | 2023-02-13 | Capital World Investors | GILEAD SCIENCES, INC. | 68,900,998 | 5.5% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | GILEAD SCIENCES, INC. | 112,038,324 | 8.9% | EDGAR |
| SC 13G | 2023-02-06 | GILEAD SCIENCES, INC. | Arcellx, Inc. | 3,478,261 | 7.3% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | GILEAD SCIENCES, INC. | 131,555,769 | 10.5% | EDGAR |